0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics

Buy Now

Painful Sex Associated with Menopause - Interpreting FDA Warnings When Choosing a Treatment for Dyspareunia (Hardcover) Loot Price: R4,107
Discovery Miles 41 070
You Save: R583 (12%)
Painful Sex Associated with Menopause - Interpreting FDA Warnings When Choosing a Treatment for Dyspareunia (Hardcover):...

Painful Sex Associated with Menopause - Interpreting FDA Warnings When Choosing a Treatment for Dyspareunia (Hardcover)

Michael W. Degregorio, Timothy B Cadman, Gregory T Wurz

 (sign in to rate)
List price R4,690 Loot Price R4,107 Discovery Miles 41 070 | Repayment Terms: R385 pm x 12* You Save R583 (12%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Dyspareunia, or painful sexual intercourse, associated with menopause has been a taboo subject for decades. During the past year, postmenopausal women have been saturated with print and television advertisements regarding two prescription treatments for painful sex associated with menopause. This book is intended to elucidate in understandable terms the two prescription options currently available for the treatment of dyspareunia, Premarin (R) (conjugated equine estrogens) Vaginal Cream and Osphena (ospemifene) oral tablets. Premarin (R) is a cocktail of hormones isolated from the urine of pregnant horses that was originally approved by the U.S. Food and Drug Administration (FDA) for the treatment of menopausal symptoms in 1942. Today, Premarin (R) remains the most commonly prescribed hormone replacement therapy (HRT). Osphena is a synthetic non-estrogen drug approved in 2013 that is classified as a selective estrogen receptor modulator (SERM). Other SERMs approved by the FDA include tamoxifen for breast cancer treatment and prevention, and Evista (R) (raloxifene) for the prevention of postmenopausal osteoporosis and reducing the risk of breast cancer. The FDA is required to educate the public about the benefits and risks of prescription drugs. Unfortunately, these messages are not always clear. We discuss, in understandable terms, the benefits and risks of Premarin (R) Vaginal Cream and Osphena oral tablets as seen in media advertisements, boxed warnings and package inserts. Throughout this book, we discuss the history of these two treatment options for dyspareunia and the future research intended to improve upon hormone replacement therapy for postmenopausal women.

General

Imprint: nova science publishers
Country of origin: United States
Release date: December 2014
Authors: Michael W. Degregorio • Timothy B Cadman • Gregory T Wurz
Dimensions: 230 x 155 x 15mm (L x W x T)
Format: Hardcover
Pages: 179
ISBN-13: 978-1-63321-929-8
Categories: Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics > General
LSN: 1-63321-929-1
Barcode: 9781633219298

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners